{"id":"W2069385780","doi":"10.1016/j.clml.2011.03.033","title":"Addition of AEG35156 XIAP Antisense Oligonucleotide in Reinduction Chemotherapy Does Not Improve Remission Rates in Patients With Primary Refractory Acute Myeloid Leukemia in a Randomized Phase II Study","year":2011,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Charles-Le Moyne; Université de Montréal; Hôpital Maisonneuve-Rosemont; Aegera Therapeutics (Canada); University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Idarubicin; Cytarabine; Medicine; Chemotherapy; Myeloid leukemia; Internal medicine; Refractory (planetary science); XIAP; Induction chemotherapy; Gastroenterology; Oncology; Randomized controlled trial; Acute leukemia; Leukemia; Pharmacology; Surgery; Apoptosis; Caspase; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001485811,0.0003763395,0.001041095,0.0002486262,0.00006713418,0.00001384768,0.0002158787,0.0005292735,0.00003718756],"category_scores_gemma":[0.000254641,0.0002745359,0.0002238296,0.0002823371,0.0002351623,0.0000472288,0.0001320551,0.0002418514,0.000002245052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005571991,"about_ca_system_score_gemma":0.0005629886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003658164,"about_ca_topic_score_gemma":0.000119543,"domain_scores_codex":[0.9962753,0.0005849039,0.001602971,0.0008673305,0.000299836,0.0003696309],"domain_scores_gemma":[0.9983048,0.0001127478,0.0007105839,0.0005910004,0.0001565276,0.0001243268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.1804242,0.003015892,0.0121952,0.00005014054,0.0001572698,0.0000475238,0.0005733942,0.00001878268,0.4795633,0.00001395484,0.00003824101,0.3239021],"study_design_scores_gemma":[0.2035767,0.004231797,0.5747704,0.0001825475,0.00007401742,0.000004113049,0.0001205861,0.0003175433,0.2160621,0.0001449075,0.0001062942,0.0004089638],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977013,0.00006443392,0.00006985717,0.000017652,0.0003184599,0.001630322,0.00003292386,0.0000195705,0.0001454213],"genre_scores_gemma":[0.9974875,0.0005770286,0.0009166923,0.0001299709,0.0001383412,0.00008639426,0.0003710806,0.00005709069,0.00023593],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5625752,"threshold_uncertainty_score":0.9999707,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01252439752775815,"score_gpt":0.2751546296371883,"score_spread":0.2626302321094302,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}